Collect immune cells by lymphapheresis to study cancer response
Treatments studied
Part of Cancer clinical trials.
This trial studies how changing your immune system (with earlier treatments) affects cancer by collecting immune cells from your blood using a process called lymphapheresis. It may help researchers find better ways to monitor immune-related responses and side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have an invasive cancer (tumor) that is confirmed or suspected, based on the study group you’re in
- You’re currently receiving treatments that can change immune function, or you recently received them
- Your doctors suspect an immune-related response or immune-related side effects
- You can have two blood access lines for lymphapheresis, and you don’t have major heart/vein problems
- Your blood has enough lymphocytes (a type of immune cell) and your tumor tissue has DNA and RNA available
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects immune and tumor-related samples to learn what predicts response to adoptive cell therapy (a treatment using immune cells). If you (or your child) are eligible, you may help researchers understand who benefits and why.
This study aims to deeply analyze immune cells and tumor cells in the blood and tumors of cancer patients. It may help researchers better understand how the immune system interacts with cancer.
This trial tests a new way to take blood from patients with solid tumors or healthy volunteers, grow immune cells in a lab, and then give them back to potentially treat cancer. It may help people whose standard options have run out.
This study looks at what makes some cancers more “noticeable” to the immune system. It may help researchers design better future immunotherapy by collecting information (often including blood samples) from people with different cancers.
This study collects blood and tumor samples to understand how well cancer immunotherapy works and what side effects may happen. It mainly helps researchers by checking “immune markers” before treatment starts, while you receive planned immune checkpoint therapy.
This study is looking at a specific type of immune cell (called TLR4+ cells) in the blood of people with solid tumors. By studying these cells, researchers hope to learn more about how the immune system reacts to cancer and to treatments.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.